|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 305, Issue 2, 593-599, May 2003
9-Tetrahydrocannabinol
Department of Pharmacology and Toxicology, Virginia Commonwealth
University, Richmond, Virginia
It has been suggested that the cannabinoid receptor type 1 (CB1), a G
protein-coupled receptor, is internalized after agonist binding and
activation of the second messenger pathways. It is proposed that
phosphorylation enhances the down-regulation of the CB1 receptor, thus
contributing to tolerance. Alterations in phosphorylation of proteins
in the signal transduction cascade after CB1receptor activation could
also alter tolerance to cannabinoids. We addressed our hypothesis by
evaluating the role of several kinases in antinociceptive tolerance to
9-tetrahydrocannabinol (THC). We evaluated
cAMP-dependent protein kinase (PKA) using KT5720, a PKA
inhibitor; protein kinase C (PKC) using bisindolylmaleimide I, HCl
(bis), a PKC inhibitor; cGMP-dependent protein kinase (PKG) using
KT5823, a PKG inhibitor;
-adrenergic receptor kinase
(
-ARK) using low molecular weight heparin (LMWH), a
-ARK
inhibitor; and phosphatidylinositol-3 kinase (PI3-K) using 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
(LY294002), a PI3-K inhibitor and PP1, a Src family tyrosine
kinase inhibitor. The cAMP analog used was dibutyryl-cAMP and the cGMP
analog used was dibutyryl-cGMP. Our data indicate that selective
kinases may be involved in cannabinoid tolerance. Mice and rats were
rendered tolerant to
9-THC. The PKG inhibitor KT5823,
the
-ARK inhibitor LMWH, the PI3-K inhibitor LY294002, and
inhibition of PKC by bis had no effect on tolerance. At a higher dose,
bis attenuated the antinociceptive effect of
9-THC in
nontolerant mice. PP1, the Src family tyrosine kinase inhibitor, and
KT5720, the PKA inhibitor, reversed THC-induced tolerance. In addition,
inhibition of PKA reversed a decrease in dynorphin release shown to
accompany THC tolerance in rats. These data support a role for PKA and
Src tyrosine kinase in phosphorylation events in
9-THC-tolerant mice.
This article has been cited by other articles:
![]() |
A. Tappe-Theodor, N. Agarwal, I. Katona, T. Rubino, L. Martini, J. Swiercz, K. Mackie, H. Monyer, D. Parolaro, J. Whistler, et al. A Molecular Basis of Analgesic Tolerance to Cannabinoids J. Neurosci., April 11, 2007; 27(15): 4165 - 4177. [Abstract] [Full Text] [PDF] |
||||